1. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis

   • Seyed-Moayed Alavian
   • Bita Behnava
   • Seyed Vahid Tabatabaei

   Review Article 21 September 2010 Pages: 1071 - 1079

   

2. Are results from pharmaceutical-company-sponsored studies available to the public?

   • Rafael Dal-Ré
   • Alejandro Pedromingo
   • Rafael Ortega

   Clinical Trial 16 September 2010 Pages: 1081 - 1089

3. Paediatric investigation plans for pain: painfully slow!

   • Elin H. Davies
   • Cecile M. Ollivier
   • Agnes Saint Raymond

   Special Article 07 September 2010 Pages: 1091 - 1097

4. Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials

   • Yong Bing Cao
   • Jun Dong Zhang
   • Yuan Ying Jiang

   Pharmacodynamics 02 September 2010 Pages: 1099 - 1108

   

5. The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone

   • Nikolina Jovanović
   • Nada Božina
   • Alma Mihaljević Peleš

   Pharmacogenetics 19 June 2010 Pages: 1109 - 1117

   

6. Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis

   • Melanie S. Joy
   • Tammy Boyette
   • Philip C. Smith

   Pharmacogenetics 22 June 2010 Pages: 1119 - 1130

7. Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism

   • Hui-Yan Shi
   • Jin Yan
   • Dong-Sheng Ouyang

   Pharmacokinetics and Disposition Open access 29 July 2010 Pages: 1131 - 1136

   

8. Proposal of a new limited sampling strategy to predict CYP3A activity using a partial AUC of midazolam

   • Stephanie Katzenmaier
   • Christoph Markert
   • Gerd Mikus

   Pharmacokinetics and Disposition 03 August 2010 Pages: 1137 - 1141

   

9. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands

   • Florence van Hunsel
   • Christine van der Welle
   • Kees van Grootheest

   Pharmacoepidemiology and Prescription Open access 24 July 2010 Pages: 1143 - 1150

   

10. Psychiatric comorbidity in patients with epilepsy: a population-based study

    • Mohamad Karouni
    • Subaneesan Arulthas
    • Cecilie Johannessen Landmark

    Pharmacoepidemiology and Prescription 29 July 2010 Pages: 1151 - 1160

    

11. The local vasoconstriction of infant’s skin following instillation of mydriatic eye drops

    • Atilla Alpay
    • Bahri Ermis
    • Haci Murat Sagdik

    Short Communication 11 September 2010 Pages: 1161 - 1164

    

12. Effect of CYP2C19 genotypes on the pharmacokinetic/pharmacodynamic relationship of rabeprazole after a single oral dose in healthy Chinese volunteers

    • Yu-Cheng Sheng
    • Kun Wang
    • Qing-Shan Zheng

    Short Communication 14 September 2010 Pages: 1165 - 1169

    

13. Interaction between topical miconazole and coumarins

    • Nancy Broos
    • Eugène P. van Puijenbroek

    Letter to the Editors 25 July 2010 Pages: 1171 - 1172

14. Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine

    • Amir M. Nia
    • Uwe Fuhr
    • Fikret Er

    Letter to the Editors 31 July 2010 Pages: 1173 - 1175